ISRAA ALI: Open Payments
NPI 1841687720 · LEAGUE CITY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,750 in 66 payments from 20 companies in 2025. Trend: 2023 $1,058 · 2024 $1,431 · 2025 $1,750
Food & beverage: $1,750
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 11 | $386 |
| Lilly USA, LLC | 8 | $248 |
| Amgen Inc. | 4 | $183 |
| Madrigal Pharmaceuticals | 4 | $131 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $120 |
| Ascendis Pharma Endocrinology Inc | 5 | $119 |
| Corcept Therapeutics | 5 | $113 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $69 |
| Xeris Pharmaceuticals, Inc. | 3 | $58 |
| Novo Nordisk Inc | 3 | $57 |
Products named: CRENESSITY, EVENITY, REZDIFFRA, JARDIANCE, ZEPBOUND, Kerendia, Yorvipath, Korlym.
Industry payments across TX — which companies pay providers there.
